Organization: Health Canada
Year: 2022
Month: May
Request Number: A-2021-002018
Request Summary: The Screening Acceptance Letter(s) from Health Canada to all & any generic drug manufacturer(s) related to all and any Abbreviated New Drug Submission(s) for the medicinal ingredient risperidone which appear(s) on the list of Generic Drug Submissions Under Review (GSUR).
Disposition: Disclosed in part
Number of pages: 1